drugset / Trial / NCT02556060

Lamotrigine for Ketamine Dependence Trial

NCT02556060

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy of lamotrigine in the treatment of ketamine dependence in a double-blind, placebo controlled design.

Timeline

Start
2015-09
Primary completion
2017-05-01
Completion
2017-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 200 mg

Indications